Join us in congratulating Karen Lu, MD Moffitt’s Physician in Chief, as she takes the helm as President of Society of Gynecologic Oncology! This opportunity highlights her dedication to advancing gynecologic cancer care, driving innovation and saving lives. ????
Moffitt Cancer Center
医院和医疗保健
Tampa，FL 80,126 位关注者
To contribute to the prevention and cure of cancer
关于我们
At Moffitt Cancer Center, we come face-to-face with cancer every day, but we also see courage. And it inspires us to be the safest and best place for cancer care – to bring greater hope to every patient we serve. It’s why we’ve been continually named One of the Top Places to Work in the Tampa Bay Area. As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt employs some of the best and brightest minds from around the world. Moffitt is the top cancer hospital in Florida according to U.S. News & World Report and has been nationally ranked since 1999. Because working at Moffitt is both a career and a mission: to contribute to the prevention and cure of cancer. Join a dedicated, diverse and inclusive team of over 7,000 to be a part of the Courageous future we envision.
- 网站
-
https://moffitt.org
Moffitt Cancer Center的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 5,001-10,000 人
- 总部
- Tampa，FL
- 类型
- 非营利机构
- 创立
- 1986
- 领域
- Magnet recognition granted by the American Nurses Credentialing Center、NCI-designated Comprehensive Cancer Center、DiversityInc’s Top Hospitals & Health Systems list、Tampa Bay Times Top Workplaces、Computerworld’s 100 Best Places to Work in IT、Leader in LGBTQ Healthcare Equality和Top cancer hospital in Florida and the Southesast according to U.S. News & World Report
地点
Moffitt Cancer Center员工
动态
-
Clinical trials help researchers understand the unique characteristics of rare cancers, develop targeted therapies, and improve patient outcomes. https://lnkd.in/gYhWqsgY
-
Hear Bruna Pellini, MD of?Moffitt Cancer Center?present key data comparing real-world outcomes of atezolizumab versus durvalumab in ES-SCLC, demonstrating a significant overall survival advantage and lower immune-related adverse events with durvalumab. Watch here:?https://lnkd.in/g4F-GmCJ
-
Glioblastoma is one of the most challenging brain cancers to treat, but a new clinical trial at Moffitt is changing that. Using SonoCloud-9 technology, this approach temporarily opens the blood-brain barrier, allowing chemotherapy to reach cancer cells more effectively. This innovation offers new possibilities for patients with recurrent GBM. Learn more about the trial: https://lnkd.in/ei4itaGh
-
Congratulations to Brandon Blue, MD, who was recognized for his groundbreaking work in cancer research and his advocacy for equitable healthcare at the KBLA Talk Gala! Learn more ?? https://lnkd.in/emAH_kF2 #MoffittCancerCenter #CancerResearch
-
-
In honor of National Women's History Month, we recognize just a few of the women contributing to Moffitt's mission. https://lnkd.in/ef9PmwwJ
-
Join us for the 18th annual Business of Biotech conference, Tampa Bay's premier event for biotech innovation. The conference attracts 400+ biotech executives, entrepreneurs, venture capitalists, angel investors and researchers to discuss the latest advances in cancer care. Check out the highlights from last year's event! #MoffittBoB ?? Register now: https://lnkd.in/epnV9xnD
-
#NowHiring | Moffitt is hiring a Director of Care Management to lead and enhance our care management strategy! This role provides leadership, oversight, and consultation to ensure compliance with industry standards and regulations—all while making a meaningful impact on patient care Apply now: https://lnkd.in/e59WQprz
-
?? The Pathology Revolution: Precision Medicine In a thought-provoking interview, Dr. Marilyn Bui discusses how digital pathology and AI are reshaping the landscape of precision medicine. "Pathologists play a crucial role in making diagnosis, identifying disease drivers, and discovering biomarkers by analyzing patient samples. By studying the diseases at the levels of tissue, cell, protein, and gene, we provide critical insight into how to effectively treat them. Pathology is the magical sword that arms the dragon slayers, who are our patient-facing clinical colleagues, fighting to conquer the beasts." Marilyn also delves into how these technologies are driving the evolution of the field, improving workflows, and creating more tailored healthcare solutions. Learn about the future of pathology and its pivotal role in precision medicine. ?? Read the full interview: https://ow.ly/Vee450V5nkv #DigitalPathology #PrecisionMedicine #Pathology #ClinicalPathology #Pathologist
-